Nursing care in critically ill patients with ischemic stroke requiring alteplase therapy
DOI:
https://doi.org/10.35381/s.v.v7i1.3592Keywords:
Stroke, brain ischemia, ischemic attack, transient, (Source: DeCS)Abstract
Objective: To describe nursing care in critically ill patients with ischemic stroke requiring treatment with alteplase. Method: Descriptive documentary study. Results and Conclusion: The care protocols provided by the nurse to the patient are fundamental to guarantee clinical improvement and minimize the possible permanent disabling sequelae of stroke patients. All interventions should be adapted and modified based on the clinical context of the patient, focusing on the control of vital signs, neurological assessment, application of neurological scales, among others, all of these carried out before, during and after the administration of alteplase.
Downloads
References
Boursin P, Paternotte S, Dercy B, Sabben C, Maïer B. Sémantique, épidémiologie et sémiologie des accidents vasculaires cérébraux [Semantics, epidemiology and semiology of stroke]. Soins. 2018;63(828):24-27. https://doi.org/10.1016/j.soin.2018.06.008
Rahayu UB, Wibowo S, Setyopranoto I, Hibatullah Romli M. Effectiveness of physiotherapy interventions in brain plasticity, balance and functional ability in stroke survivors: A randomized controlled trial. NeuroRehabilitation. 2020;47(4):463-470. https://doi.org/10.3233/NRE-203210
Manners J, Steinberg A, Shutter L. Early management of acute cerebrovascular accident. Curr Opin Crit Care. 2017;23(6):556-560. https://doi.org/10.1097/MCC.0000000000000462
Kvistad CE, Næss H, Helleberg BH, et al. Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial. Lancet Neurol. 2022;21(6):511-519. https://doi.org/10.1016/S1474-4422(22)00124-7
Thelengana A, Radhakrishnan DM, Prasad M, Kumar A, Prasad K. Tenecteplase versus alteplase in acute ischemic stroke: systematic review and meta-analysis. Acta Neurol Belg. 2019;119(3):359-367. https://doi.org/10.1007/s13760-018-0933-9
Thommessen B, Næss H, Logallo N, et al. Tenecteplase versus alteplase after acute ischemic stroke at high age. Int J Stroke. 2021;16(3):295-299. https://doi.org/10.1177/1747493020938306
Thommessen B, Næss H, Logallo N, et al. Tenecteplase versus alteplase after acute ischemic stroke at high age. Int J Stroke. 2021;16(3):295-299. https://doi.org/10.1177/1747493020938306
Alemseged F, Ng FC, Williams C, et al. Tenecteplase vs Alteplase Before Endovascular Therapy in Basilar Artery Occlusion. Neurology. 2021;96(9):e1272-e1277. https://doi.org/10.1212/WNL.0000000000011520
García Alfonso C, Martínez Reyes A, García V, Ricaurte-Fajardo A, Torres I, Coral J. Actualización en diagnóstico y tratamiento del ataque cerebrovascular isquémico agudo [Update on the diagnosis and treatment of acute ischemic stroke]. Univ. Med. 2019;60(3):41-57.
Coronel Gaviria Anabeli, Chilito Paulo Andrés, Cabrera Velasco Carlos Ernesto, Zamora Bastidas Tomas, Vargas Uricoechea Hernando. Trombólisis endovenosa en ACV isquémico: experiencia en un hospital de Popayán, Cauca [Intravenous thrombolysis in ischemic stroke: Experience in a Popayán hospital, Cauca]. Acta Neurol Colomb. 2020;36(1):11-17.
Rojas-Benites M, Campos-Flores L, Cancino-Díaz J, Carranza-Jordán E, Castillo-Zegarra L, Cruz-Rodríguez J, De la Cruz-Araujo W. Hemorragia subaracnoidea como complicación de trombólisis endovenosa en una paciente con accidente cerebro vascular isquémico [Subarachnoid hemorrhage as a complication of endovenous thrombolysis in an ischemic stroke patient]. Revista de Neuro-Psiquiatría. 2022;84(4):333-8.
Orellana-Urzúa S, Rojas I, Líbano L, Rodrigo R. Pathophysiology of Ischemic Stroke: Role of Oxidative Stress. Curr Pharm Des. 2020;26(34):4246-4260. https://doi.org/10.2174/1381612826666200708133912
Boese AC, Le QE, Pham D, Hamblin MH, Lee JP. Neural stem cell therapy for subacute and chronic ischemic stroke. Stem Cell Res Ther. 2018;9(1):154. https://doi.org/10.1186/s13287-018-0913-2
Malik P, Patel UK, Kaul S, et al. Risk factors and outcomes of intravenous tissue plasminogen activator and endovascular thrombectomy utilization amongst pediatrics acute ischemic stroke. Int J Stroke. 2021;16(2):172-183. https://doi.org/10.1177/1747493020904915
Meurer WJ, Barth B, Abraham M, Hoffman JR, Vilke GM, DeMers G. Intravenous Recombinant Tissue Plasminogen Activator and Ischemic Stroke: Focused Update of 2010 Clinical Practice Advisory From the American Academy of Emergency Medicine. J Emerg Med. 2018;54(5):723-730. https://doi.org/10.1016/j.jemermed.2018.01.033
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Ana María Curicho-León, Neris Marina Ortega-Guevara, Yarintza Coromoto Hernandez-Zambrano, Yeisy Cristina Guarate-Coronado
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.
